Eventide Asset Management’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $19.4M | Hold |
|
|||||
|
2020
Q4 | $18.3M | Hold |
|
|||||
|
2020
Q3 | $16.1M | Hold |
|
|||||
|
2020
Q2 | $13.6M | Hold |
|
|||||
|
2020
Q1 | $12.8M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $6M | Hold |
|
|||||
|
2018
Q4 | $5.61M | Hold |
|
|||||
|
2018
Q3 | $7.38M | Sell |
|
|||||
|
2018
Q2 | $25.7M | Hold |
|
|||||
|
2018
Q1 | $20.7M | Sell |
|
|||||
|
2017
Q4 | $27.8M | Hold |
|
|||||
|
2017
Q3 | $24.4M | Hold |
|
|||||
|
2017
Q2 | $19.9M | Hold |
|
|||||
|
2017
Q1 | $17.3M | Buy |
|
|||||
|
2016
Q4 | $10.9M | Hold |
|
|||||
|
2016
Q3 | $15.5M | Hold |
|
|||||
|
2016
Q2 | $14.6M | Buy |
|
|||||
|
2016
Q1 | $11.2M | Buy |
|
|||||
|
2015
Q4 | $6.02M | Buy |
|
|||||
|
2015
Q3 | $2.17M | Hold |
|
|||||
|
2015
Q2 | $2.76M | Hold |
|
|||||
|
2015
Q1 | $3.31M | Buy |
|
|||||
|
2014
Q4 | $2.42M | Hold |
|
|||||
|
2014
Q3 | $1.88M | Hold |
|
|||||
|
2014
Q2 | $2.11M | Buy |
|